Neural regeneration pathway

"Neural regeneration pathway" collectively describes the group of molecular mechanisms, signaling cascades, and cellular processes that facilitate the regrowth or repair of damaged neurons and neural circuits. These pathways involve neurotrophic factors (such as NGF, BDNF, GDNF, FGF-2, NT-3, and CNTF), transcription factors (like EGR1, NR4A1), and multiple downstream intracellular signaling networks (e.g., MAPK, cAMP, Ras, JNK). These pathways regulate key events such as axonal regeneration, neurite outgrowth, myelination, neural precursor proliferation, and synaptic plasticity. Rather than being a single pharmacological target, they encompass a broad therapeutic focus in neurology, aiming to restore neural function after injury or neurodegeneration. Current research focuses on identifying specific molecular nodes within these pathways (e.g., neurotrophic factor receptors, key transcription factors) as druggable targets for regenerative therapies[2][3][4][5][6]. Because "Neural regeneration pathway" is not a molecule, receptor, or druggable entity, but a functional concept or network, it is not suitable as a structured therapeutic target entry per standard pharmacological convention.

Other names

Neural regeneration signalingNerve regeneration pathwaysAxonal regeneration pathway

Activation of neurotrophic factor signaling to promote neuronal survival and axon regeneration[4][5] Modulation of transcription factors regulating neural differentiation and growth[2][5] Enhancement of neurite extension and plasticity via kinase pathways (e.g., MAPK, cAMP, ERK)[3][4]